CTOs on the Move

Medically Home

www.medicallyhome.com

 
We bring the hospital to you! We deliver advanced medical care to where and when patients and their families want and need it. The Medically Home Program gives you more care over a longer period of time. We know getting well from a hospital-level illness or surgical procedure takes weeks, not days. With the Medically Home Program, you get the time you need - at home - with a single care team available to you the entire time. One of the secrets to getting better is being involved in – and understanding – your own care. The more time you ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Medically Home raised $10M on 05/28/2019
Medically Home raised $40.4M on 11/04/2020
Medically Home raised $100M on 05/13/2021

Similar Companies

DocuSys, Inc.

DocuSys, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Atlanta, GA. To find more information about DocuSys, Inc., please visit www.docusys.net

Roselani Place

Roselani Place is a Kahului, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Habit

Discover what nutrients your body craves at the cellular level. Habit delivers the first complete personalized nutrition solution, From Test to Table

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.

Technology Commercialization Group

Technology Commercialization Group is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.